GGrantIndex
← Search

Leadership Planning and Evaluation

$625,450P30FY2021CANIH

Vanderbilt University Medical Center, Nashville TN

Investigators

Linked publications, trials & patents

Trial NCT07016399Trial NCT06593106Trial NCT05501665Trial NCT05361720Trial NCT04765072Trial NCT02702310Trial NCT02685631Trial NCT02677883Trial NCT02676752Trial NCT02672475Trial NCT02658487Trial NCT02600533Trial NCT02489422Trial NCT02480114Trial NCT02457910Trial NCT02448225Trial NCT02440737Trial NCT02374931Trial NCT02359851Trial NCT02324881Trial NCT02296112Trial NCT02269111Trial NCT02240381Trial NCT02236546Trial NCT02170272Trial NCT02151539Trial NCT02148406Trial NCT01996527Trial NCT01928160Trial NCT01901367Trial NCT01660971Trial NCT01230515Trial NCT01198535Trial NCT01141218Trial NCT01098669Trial NCT01098643Trial NCT01096407Trial NCT01096394Trial NCT01096381Trial NCT01077440Trial NCT01031446Trial NCT01013506Trial NCT01009931Trial NCT01007422Trial NCT00993694Trial NCT00993135Trial NCT00987766Trial NCT00984542Trial NCT00984490Trial NCT00983268Trial NCT00957736Trial NCT00949052Trial NCT00930930Trial NCT00900406Trial NCT00900003Trial NCT00899769Trial NCT00899626Trial NCT00899457Trial NCT00899301Trial NCT00899028Trial NCT00898742Trial NCT00898638Trial NCT00898430Trial NCT00898313Trial NCT00897988Trial NCT00897832Trial NCT00897793Trial NCT00897650Trial NCT00897468Trial NCT00897403Trial NCT00897117Trial NCT00896948Trial NCT00896675Trial NCT00892801Trial NCT00875238Trial NCT00840814Trial NCT00837876Trial NCT00835679Trial NCT00801346Trial NCT00765245Trial NCT00755040Trial NCT00675636Trial NCT00670644Trial NCT00670605Trial NCT00670046Trial NCT00666211Trial NCT00656604Trial NCT00653250Trial NCT00651976Trial NCT00651716Trial NCT00647218Trial NCT00626873Trial NCT00625417Trial NCT00625066Trial NCT00616590Trial NCT00601991Trial NCT00573404Trial NCT00550537Trial NCT00544648Trial NCT00533884

Abstract

CCSG COMPONENT 001 ? LEADERSHIP, PLANNING AND EVALUATION PROJECT SUMMARY/ABSTRACT The Vanderbilt-Ingram Cancer Center (VICC) has a dynamic and diverse leadership team that encompasses expertise across all facets of the cancer research and clinical enterprises and provides oversight of basic, clinical, translational, prevention, control and population-based research programs. Working collaboratively and effectively, the senior leaders have enhanced organizational capabilities, and planning and evaluation activities to reduce the cancer burden in our community and globally. Leadership, Planning and Evaluation activities provide a structured workstreams for assessing our current status, identifying opportunities and formulating approaches for implementing the VICC mission. VICC carries out internal and external evaluation and strategic planning to inform and support its decision-making processes. The significant accomplishments of VICC membership and leadership, described throughout this renewal application, provide evidence of an effective and productive leadership team and the use of planning and evaluation (internal and external) processes. Since the last competing renewal a new strategic plan was initiated with a focus on expansion of research programs through continued recruitment of 67 talented investigators that joined the VICC membership and collectively advanced scientific discovery. As the goals of the 2014-2019 VICC Strategic Plan have been largely accomplished, in 2017, the Director and Senior Leadership embarked upon a new strategic planning process, which has been approved for the next project period and endorsed by the External Scientific Advisory Board (ESAB). The intent of the plan is to continue to invest in programs and people that are essential for continued translation of discoveries to patients, expand select areas of research as dictated by needs and opportunities and further strengthen the position of the matrix Center within the region, nation and worldwide. Key objectives of the new plan include: 1) advancing fundamental discoveries, 2) moving discoveries to interventions, 3) enabling a systems approach to cancer, and 4) reducing cancer disparities and burden. External evaluation is provided by the ESAB, Community Advisory Board, and Board of Overseers; providing expert guidance and insights to VICC leadership and membership on opportunities for collaborations and engagement, catchment area needs, development of programs, merit of research accomplishments and feedback on performance. Several internal mechanisms provide comprehensive planning and evaluation within VICC; these include the Executive Committee, Research Program Leaders Committee, Shared Resource Oversight Group, CRCERA Advisory Committee, and others. Together, these external and internal evaluation groups provide advice to the Director, who has ultimate responsibility and authority for setting the vision and priorities for the Center as a whole in order to promote transdisciplinary scientific advances that can be translated to patients and community.

View original record on NIH RePORTER →